2002 Cell Biology Doctors 
Drug Discovery World
AUGUST 5, 2022
from 2002 as a Protein Engineer and major contributor to its disruptive NGS technology. Prior to that, Sanches-Kuiper was a post-doctoral researcher in the Department of Chemical Engineering and Biotechnology, University of Cambridge, in the area of cancer gene therapy.
Drug Target Review
JUNE 29, 2023
I think the cell-therapy field has evolved a lot – and is continuing to do so – in the time I’ve been working with this. Regarding the NY-ESO programme that we worked on, I started work on that in 2002 before we even knew that we were going to do cell therapy.
Expert insights. Personalized for you.
130 
Let's personalize your content